[Kaposi disease, limited to the skin, in ulcerated hemorrhagic rectocolitis].
We report the first case of limited cutaneous Kaposi's sarcoma during ulcerative colitis, in a HIV-negative 68 year-old man without any risk factors for this tumor. In our case, the steroid-therapy necessitated by the colitis is the most important aetiological factor of the sarcoma and its withdrawal leads to a complete remission of the tumor. The link between steroid-therapy and Kaposi's sarcoma is well known. A link between ulcerative colitis and Kaposi's sarcoma can be discussed but not proven. The possible occurrence of this cutaneous tumor during ulcerative colitis is of interest.
Bolla
G
G
Service de médecine interne, CHU La Timone, bd Jean-Moulin, Marseille, France.
Disdier
P
P
Swiader
L
L
Andrac
L
L
Vacheret
H
H
Sahel
J
J
Harlé
J R
JR
Weiller
P J
PJ
D000368:Aged; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012307:Risk Factors; D012514:Sarcoma, Kaposi / Q000209:etiology*; D012878:Skin Neoplasms / Q000209:etiology*
D011241:Prednisone
Maladie de Kaposi strictement cutanée au cours d'une rectocolite ulcérohémorragique.